Helicos Narrows Q2 Loss on Lower Costs

Helicos cut its net loss through a steep decline in R&D and SG&A spending. The firm also said that it is actively seeking financing as its cash on hand fell to $5 million as of today.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.